Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Life Insurance Co ( (HK:2628) ) has shared an announcement.
China Life Insurance Company Limited has announced a connected transaction involving the formation of a partnership with CNNP and the China-Russia Nuclear Industry Fund as limited partners, and Guangzhou Jinhong and CNNC-IFMC as general partners. The partnership will have a total capital contribution of RMB1,501,000,000, with China Life contributing RMB1,200,000,000. This strategic move is aimed at optimizing asset allocation and enhancing investment capabilities, with China Life Jinshi serving as the manager of the partnership.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$19.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major player in the insurance industry, primarily offering life insurance products and services. The company is focused on providing comprehensive insurance solutions and is a significant entity in the Chinese market.
Average Trading Volume: 71,225,905
Technical Sentiment Signal: Buy
Current Market Cap: HK$1115.2B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.